FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndFree cash flow (Million JPY)YoY (%)
Mar 31, 2025670-55.32%
Mar 31, 20241,500-238.33%
Mar 31, 2023-1,084-146.83%
Mar 31, 20222,315+17.76%
Mar 31, 20211,966-544.04%
Mar 31, 2020-443-192.53%
Mar 31, 2019479-62.74%
Mar 31, 20181,284-343.93%
Mar 31, 2017-526+821.13%
Mar 31, 2016-57-106.97%
Mar 31, 2015820
AI Chat